That's a helpful quote...although still, I get the feeling from reading that they were pressured to include the public for not exactly the highest scientific reasons...(i.e. a sop to the Ivermectin adherents, one of whom is in my extended family...sigh...)

Since NP got CYDY so ahead of its skis before, and so many investors were trying to communicate with the FDA, I still feel it would have been better to write the company and make sure they're aware of the opportunity so *they*could write with more capital, iykwim,, rather than lump LL in with the perfume and horse dewormer and god knows what else submissions...we need to err on the side of formal procedure, IMO.